SOSV

Founded in 1995, SOSV is a global venture capital firm headquartered in New Jersey. It focuses on seed-to-growth stage investments in deep tech innovations, primarily in bio-tech/life sciences and hardware/robotics sectors, with a commitment to human and planetary health.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

William Bao Bean

General Partner

Hugh Bowen

Associate

Shawn Broderick

Venture Partner

Past deals in Infants

Free to Feed

Seed Round in 2022
Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Free to Feed

Pre Seed Round in 2022
Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Cradlewise

Seed Round in 2021
Cradlewise develops intelligent baby cribs that learn a baby's sleep patterns, mimicking a parent's soothing motion to help lull them back to sleep. Its smart cradles monitor infant health and activity, including breath rate, posture, and movement, aiming to enhance parental care and reduce the risk of sudden infant death syndrome.

Free to Feed

Seed Round in 2021
Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Babybe

Debt Financing in 2020
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe

Convertible Note in 2019
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Cradlewise

Convertible Note in 2019
Cradlewise develops intelligent baby cribs that learn a baby's sleep patterns, mimicking a parent's soothing motion to help lull them back to sleep. Its smart cradles monitor infant health and activity, including breath rate, posture, and movement, aiming to enhance parental care and reduce the risk of sudden infant death syndrome.

Cradlewise

Seed Round in 2019
Cradlewise develops intelligent baby cribs that learn a baby's sleep patterns, mimicking a parent's soothing motion to help lull them back to sleep. Its smart cradles monitor infant health and activity, including breath rate, posture, and movement, aiming to enhance parental care and reduce the risk of sudden infant death syndrome.

Sweetie Pie Organics

Seed Round in 2019
Sweetie Pie Organics is a brand that makes organic snacks for toddlers and nutritional products for pregnant and new mothers. Toddler snacks use organic produce grown on U.S. farms, are freeze-dried to preserve natural taste, and are packed in recyclable packaging. They contain no added ingredients and are 100% fruits and vegetables, melting in the mouth for easy consumption. The portfolio for mothers includes organic and gluten-free smoothies and snacks designed to support health during pregnancy and breastfeeding, featuring natural galactagogues like fenugreek to help lactation and alleviate morning nausea, while delivering essential nutrients.

Babybe

Convertible Note in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Oyalabs

Seed Round in 2018
Our mission is to translate ground-breaking science into innovative products that empower families to raise lifelong learners. Founded by a Stanford neuroscientist and a father of 2 young boys, our first product is Wunder, which is the first personalized, science-based platform to help new parents lead their little ones learning journey through play, imagination, and collaborative curiosity. The first idea for Oyalabs came about when our founder's first son was born with a congenital medical condition and he was looking for a science-based resource for parents to ensure they are stimulating not just physical but also cognitive development of their child - knowing 0-3 is the most critical period for intervention as 90% of the brain grows then. After positive results from a clinical study, in Summer 2017, we created Wunder to help harness predictive technologies to build tools to nurture not only Lamont’s own sons, as well as something meaningful and impactful for all families. Our technology has been shown to improve a child's language and cognitive outcomes in a research trial and has won the Best of BabyTech Learn & Play award at CES 2018. Based on the data and interactive curriculum in the Wunder app, the platform recommends parents age-appropriate activities, books and toys to teach and motivate parents to provide the most stimulating learning experience for their everyday bonding. Wunder is currently in Beta and parents with children between 0-24 months can apply to get access here: www.hellowunder.com/beta

Babybe

Series A in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Hello, Peanut!

Seed Round in 2017
Hello, Peanut™ enables parents to easily and gradually introduce small amounts of peanut to their infant, as early as five months of age, over the course of seven days. It is designed to be mixed into first stage foods, and thus can be presented much earlier than other peanut products. After the introductory week, the Hello, Peanut!™ maintenance packets are recommended for infants until they can eat peanut in spread or whole form. Hello, Peanut!™ is geared toward the general infant population. High risk infants (history of eczema and/or existing food allergy) need to be evaluated by their pediatrician or allergist prior to peanut introduction. Hello, Peanut!™ is not designed to treat or cure any form of food allergy.

Babybe

Convertible Note in 2017
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Hello, Peanut!

Seed Round in 2017
Hello, Peanut™ enables parents to easily and gradually introduce small amounts of peanut to their infant, as early as five months of age, over the course of seven days. It is designed to be mixed into first stage foods, and thus can be presented much earlier than other peanut products. After the introductory week, the Hello, Peanut!™ maintenance packets are recommended for infants until they can eat peanut in spread or whole form. Hello, Peanut!™ is geared toward the general infant population. High risk infants (history of eczema and/or existing food allergy) need to be evaluated by their pediatrician or allergist prior to peanut introduction. Hello, Peanut!™ is not designed to treat or cure any form of food allergy.

Oyalabs

Seed Round in 2017
Our mission is to translate ground-breaking science into innovative products that empower families to raise lifelong learners. Founded by a Stanford neuroscientist and a father of 2 young boys, our first product is Wunder, which is the first personalized, science-based platform to help new parents lead their little ones learning journey through play, imagination, and collaborative curiosity. The first idea for Oyalabs came about when our founder's first son was born with a congenital medical condition and he was looking for a science-based resource for parents to ensure they are stimulating not just physical but also cognitive development of their child - knowing 0-3 is the most critical period for intervention as 90% of the brain grows then. After positive results from a clinical study, in Summer 2017, we created Wunder to help harness predictive technologies to build tools to nurture not only Lamont’s own sons, as well as something meaningful and impactful for all families. Our technology has been shown to improve a child's language and cognitive outcomes in a research trial and has won the Best of BabyTech Learn & Play award at CES 2018. Based on the data and interactive curriculum in the Wunder app, the platform recommends parents age-appropriate activities, books and toys to teach and motivate parents to provide the most stimulating learning experience for their everyday bonding. Wunder is currently in Beta and parents with children between 0-24 months can apply to get access here: www.hellowunder.com/beta

Babybe

Series A in 2016
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

BioNascent

Seed Round in 2016
BioNascent, Inc. is a San Francisco-based company founded in 2016 that specializes in producing human breast milk formulas for infants. The company aims to provide a safe and nutritious alternative to traditional infant formulas, which often rely on milk from farm animals. BioNascent's innovative approach focuses on creating vegan formula-based milk that closely mimics the composition of human breast milk, ensuring it contains essential amino acids, carbohydrates, and other vital nutrients necessary for infant development. This advancement addresses the limitations of conventional dairy-based formulas and offers parents a healthier option for infant nutrition when breastfeeding is not possible.

Babybe

Venture Round in 2015
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe

Pre Seed Round in 2014
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

Babybe

Seed Round in 2013
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.